EX-31.1 2 tmb-20200930xex31d1.htm EX-31.1

Exhibit 31.1


I, Lawrence A. Kenyon, certify that:

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Outlook Therapeutics, Inc. (the “registrant”); and
(a)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: January 28, 2021

/s/ Lawrence A. Kenyon

Lawrence A. Kenyon

Chief Executive Officer and Chief Financial Officer

(Principal Executive, Financial and Accounting Officer)